Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126278731 | 12627873 | 1 | I | 20160125 | 20160203 | 20160806 | 20160806 | PER | US-ABBVIE-16P-163-1553663-00 | ABBVIE | 73.70 | YR | F | Y | 0.00000 | 20160805 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126278731 | 12627873 | 1 | PS | VIEKIRA PAK | DASABUVIROMBITASVIRPARITAPREVIRRITONAVIR | 1 | Oral | Y | UNKNOWN | 206619 | TABLET | ||||||||
| 126278731 | 12627873 | 2 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | Y | UNKNOWN | 0 | |||||||||
| 126278731 | 12627873 | 3 | C | LISINOPRIL. | LISINOPRIL | 1 | 0 | ||||||||||||
| 126278731 | 12627873 | 4 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | ||||||||||||
| 126278731 | 12627873 | 5 | C | MULTIVITAMIN | VITAMINS | 1 | 0 | ||||||||||||
| 126278731 | 12627873 | 6 | C | LIALDA | MESALAMINE | 1 | 0 | ||||||||||||
| 126278731 | 12627873 | 7 | C | FISH OIL | FISH OIL | 1 | 0 | ||||||||||||
| 126278731 | 12627873 | 8 | C | MELOXICAM. | MELOXICAM | 1 | 0 | ||||||||||||
| 126278731 | 12627873 | 9 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 126278731 | 12627873 | 10 | C | ATIVAN | LORAZEPAM | 1 | 0 | ||||||||||||
| 126278731 | 12627873 | 11 | C | TRAMADOL. | TRAMADOL | 1 | 0 | ||||||||||||
| 126278731 | 12627873 | 12 | C | vitamin D/calcium | CALCIUMVITAMIN D | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126278731 | 12627873 | 1 | Hepatitis C |
| 126278731 | 12627873 | 2 | Hepatitis C |
| 126278731 | 12627873 | 3 | Product used for unknown indication |
| 126278731 | 12627873 | 4 | Product used for unknown indication |
| 126278731 | 12627873 | 5 | Product used for unknown indication |
| 126278731 | 12627873 | 6 | Product used for unknown indication |
| 126278731 | 12627873 | 7 | Product used for unknown indication |
| 126278731 | 12627873 | 8 | Product used for unknown indication |
| 126278731 | 12627873 | 9 | Product used for unknown indication |
| 126278731 | 12627873 | 10 | Product used for unknown indication |
| 126278731 | 12627873 | 11 | Product used for unknown indication |
| 126278731 | 12627873 | 12 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126278731 | 12627873 | Aspartate aminotransferase increased | |
| 126278731 | 12627873 | Back pain | |
| 126278731 | 12627873 | Bilirubin conjugated increased | |
| 126278731 | 12627873 | Blood bilirubin increased | |
| 126278731 | 12627873 | Chromaturia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126278731 | 12627873 | 1 | 201601 | 20160125 | 0 | |
| 126278731 | 12627873 | 2 | 201601 | 20160125 | 0 |